Literature DB >> 34464843

Molecular dynamics of the viral life cycle: progress and prospects.

Peter Eugene Jones1, Carolina Pérez-Segura1, Alexander J Bryer1, Juan R Perilla1, Jodi A Hadden-Perilla2.   

Abstract

Molecular dynamics (MD) simulations across spatiotemporal resolutions are widely applied to study viruses and represent the central technique uniting the field of computational virology. We discuss the progress of MD in elucidating the dynamics of the viral life cycle, including the status of modeling intact extracellular virions and leveraging advanced simulations to mimic active life cycle processes. We further remark on the prospects of MD for continued contributions to the basic science characterization of viruses, especially given the increasing availability of high-quality experimental data and supercomputing power. Overall, integrative computational methods that are closely guided by experiments are unmatched in the level of detail they provide, enabling-now and in the future-new discoveries relevant to thwarting viral infection.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34464843      PMCID: PMC8651149          DOI: 10.1016/j.coviro.2021.08.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.121


  96 in total

1.  The Robust Assembly of Small Symmetric Nanoshells.

Authors:  Jef Wagner; Roya Zandi
Journal:  Biophys J       Date:  2015-09-01       Impact factor: 4.033

2.  Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly.

Authors:  Katrina J Heyrana; Boon Chong Goh; Juan R Perilla; Tam-Linh N Nguyen; Matthew R England; Maria C Bewley; Klaus Schulten; Rebecca C Craven
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

3.  Atomistic simulations indicate the functional loop-to-coiled-coil transition in influenza hemagglutinin is not downhill.

Authors:  Xingcheng Lin; Jeffrey K Noel; Qinghua Wang; Jianpeng Ma; José N Onuchic
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-16       Impact factor: 11.205

4.  Electrostatics Plays a Crucial Role in HIV-1 Protease Substrate Binding, Drugs Fail to Take Advantage.

Authors:  Mohd Ahsan; Chinmai Pindi; Sanjib Senapati
Journal:  Biochemistry       Date:  2020-09-02       Impact factor: 3.162

5.  Acidic pH-Induced Conformational Changes in Chikungunya Virus Fusion Protein E1: a Spring-Twisted Region in the Domain I-III Linker Acts as a Hinge Point for Swiveling Motion of Domains.

Authors:  Bibekananda Sahoo; Naresh Kumar Gudigamolla; Tirumala Kumar Chowdary
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

6.  Unclosed HIV-1 capsids suggest a curled sheet model of assembly.

Authors:  Zhiheng Yu; Megan J Dobro; Cora L Woodward; Artem Levandovsky; Cindy M Danielson; Virginie Sandrin; Jiong Shi; Christopher Aiken; Roya Zandi; Thomas J Hope; Grant J Jensen
Journal:  J Mol Biol       Date:  2012-10-16       Impact factor: 5.469

7.  Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.

Authors:  Lu Ruan; Jodi A Hadden; Adam Zlotnick
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

8.  Mesoscale All-Atom Influenza Virus Simulations Suggest New Substrate Binding Mechanism.

Authors:  Jacob D Durrant; Sarah E Kochanek; Lorenzo Casalino; Pek U Ieong; Abigail C Dommer; Rommie E Amaro
Journal:  ACS Cent Sci       Date:  2020-02-19       Impact factor: 14.553

9.  Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.

Authors:  Oliver C Grant; David Montgomery; Keigo Ito; Robert J Woods
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

10.  Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.

Authors:  Qi Yang; Thomas A Hughes; Anju Kelkar; Xinheng Yu; Kai Cheng; Sheldon Park; Wei-Chiao Huang; Jonathan F Lovell; Sriram Neelamegham
Journal:  Elife       Date:  2020-10-26       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.